Skip to content
Functional Ultrasound Brain-Computer Interfaces (fUS-BCIs)
Future Tech

Curated by Surfaced Editorial·Healthcare·3 min read
Share:

Functional Ultrasound Brain-Computer Interfaces (fUS-BCIs) are a non-invasive technology that uses high-frequency ultrasound waves to detect subtle changes in cerebral blood flow, a proxy for neural activity, with high spatial resolution. This technique works by emitting ultrasound pulses and measuring the echoes, allowing for detailed mapping of brain activity in real-time. Key organizations pioneering this research include Caltech, particularly the labs of Mikhail Shapiro and Richard Andersen, and Columbia University under Elisa Konofagou. The technology is currently in the advanced research and prototype stage, primarily tested in animal models and early human feasibility studies. A significant milestone occurred in 2023, when Caltech researchers published in *Nature Neuroscience* demonstrating successful decoding of imagined speech sounds from non-human primates using fUS, showcasing its potential for high-resolution neural decoding. Unlike traditional non-invasive BCIs like EEG or fNIRS which offer lower spatial resolution, fUS provides imaging capabilities closer to fMRI but in a more compact and potentially mobile format.

Why It Matters

This technology promises to revolutionize non-invasive brain monitoring and control, potentially impacting millions globally suffering from conditions like paralysis or communication disorders by providing a high-resolution, accessible BCI. In everyday life, a person with locked-in syndrome could fluidly control a robotic arm or communicate complex thoughts with precision, far exceeding current capabilities, or individuals could enhance cognitive functions non-invasively. If successful, academic institutions and specialized medical device companies would win, while developers of lower-resolution non-invasive BCIs might face disruption. Key barriers include miniaturization of ultrasound transducers, improving signal-to-noise ratio in deeper brain regions, and developing robust real-time decoding algorithms; regulatory approval for medical use will also be a hurdle. A realistic timeline for widespread clinical adoption is 10-15 years, with countries like the US, China, and France racing to lead in neuroimaging and BCI development. A second-order consequence is the ethical debate around ubiquitous, high-resolution non-invasive brain reading, potentially blurring lines of privacy and thought.

Development Stage

Early Research
Advanced Research
Prototype
Early Commercialization
Growth Phase

Enjoyed this? Get five picks like this every morning.

Free daily newsletter — zero spam, unsubscribe anytime.